Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer - Swain, S M; Baselga, J; Kim, S B; Ro, J; Semiglazov, V; Campone, M; Ciruelos, E; Ferrero, J M; Schneeweiss, A; Heeson, S (N Engl J Med, 2015)
et al.